| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Research Officer | Senior Vice President, R&D | Senior Vice President, R&D
1 company
Rote William E. serves as a Chief Research Officer at TVTX. Across recent SEC filings that breaks down to 0 buys and 51 sells. Those positions are worth an estimated $7.4M at current prices.
Historically, Rote William E.'s trades have earned a middling insider score of 58/100 across 20 rated trades. Over a 12-month horizon, 44.4% of those trades were profitable, with an average 12-month return of -15.7%.
The biggest single holding is TVTX (~$7.4M) as Chief Research Officer. The recent filings there lean toward selling, a net 164,628 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Feb 8, 2021 | TVTX Travere Therapeutics, Inc. | Senior Vice President, R&D | Sell | 4,500 | $31.50 | $141,727.50 | -5.5% | |
| Feb 3, 2021 | TVTX Travere Therapeutics, Inc. | Senior Vice President, R&D | Sell | 3,625 | $28.91 | $104,798.75 | -4.6% | |
| Feb 2, 2021 | TVTX Travere Therapeutics, Inc. | Senior Vice President, R&D | Sell | 3,625 | $30.75 | $111,468.75 | -4.1% | |
| Nov 16, 2020 | TVTX Travere Therapeutics, Inc. | Senior Vice President, R&D | Sell | 2,500 | $23.96 | $59,900.00 | -9.4% | |
| Nov 13, 2020 | TVTX Travere Therapeutics, Inc. | Senior Vice President, R&D | Sell | 2,500 | $23.62 | $59,056.00 | -8.6% | |
| Sep 23, 2020 | TVTX Travere Therapeutics, Inc. | Senior Vice President, R&D | Sell | 1,500 | $18.48 | $27,720.00 | -5.9% | |
| Sep 22, 2020 | TVTX Travere Therapeutics, Inc. | Senior Vice President, R&D | Sell | 1,500 | $18.59 | $27,885.00 | -5.5% | |
| May 12, 2020 | TVTX Travere Therapeutics, Inc. | Senior Vice President, R&D | Sell | 2,152 | $16.28 | $35,039.00 | -2.9% | |
| Mar 10, 2020 | TVTX Travere Therapeutics, Inc. | Senior Vice President, R&D | Sell | 3,250 | $14.87 | $48,327.50 | -11.2% | |
| Feb 18, 2020 | TVTX Travere Therapeutics, Inc. | Senior Vice President, R&D | Sell | 2,500 | $16.64 | $41,587.50 | -4.5% |